ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Quantum Leap Healthcare, G1 Therapeutics Announce Trilaciclib Evaluation americanpharmaceuticalreview
January 16, 2020Quantum Leap Healthcare Collaborative? and G1 Therapeutics announced a collaboration to evaluate trilaciclib, an investigational therapy designed to improve outcomes for people with cancer treated with chemotherapy, in a new randomized ... -
Olaparib, Durvalumab for I-SPY 2 Trial Announces
americanpharmaceuticalreview
September 10, 2018Quantum Leap Healthcare Collaborative (QLHC) announced that a new randomized, investigational treatment arm for the I-SPY 2 TRIAL includes the study of olaparib and durvalumab, two agents from AstraZeneca.
Pharma Sources Insight July 2025
